Radioembolization in the Treatment of Neuroendocrine Tumor Metastases to the Liver
Surgical excision remains the preferred treatment for resectable hepatic metastases of neuroendocrine tumors. In cases of more disseminated hepatic disease, transarterial radioembolization with Yttrium-90- (90Y-) labeled microspheres has been demonstrated as a viable option for symptom and locoregio...
Saved in:
Main Authors: | Martin Vyleta, Douglas Coldwell |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2011-01-01
|
Series: | International Journal of Hepatology |
Online Access: | http://dx.doi.org/10.4061/2011/785315 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy and Prognostic Factors for Y-90 Radioembolization (Y-90) in Metastatic Neuroendocrine Tumors with Liver Metastases
by: Erica S. Tsang, et al.
Published: (2020-01-01) -
Treatment of Liver Metastases in Patients with Neuroendocrine Tumors
by: Dan Granberg, et al.
Published: (2012-01-01) -
Treatment of Liver Metastases in Patients with Neuroendocrine Tumors of Gastroesophageal and Pancreatic Origin
by: Ping Gu, et al.
Published: (2012-01-01) -
Surgical Treatment of Liver Metastases in Neuroendocrine Neoplasms
by: Palepu Jagannath, et al.
Published: (2012-01-01) -
Comprehensive single-cell atlas of colorectal neuroendocrine tumors with liver metastases: unraveling tumor microenvironment heterogeneity between primary lesions and metastases
by: Yiqiao Deng, et al.
Published: (2025-01-01)